SahmAdrangi Pioneers Investing Against One Upcoming Stock

Through his firm Kerrisdale Capital Management, SahmAdrangi has managed to accumulate funds of $100 million through short sales in order to invest against a soon-to-be publicly traded company. Adrangi strived to show clients his own knowledge and insight in regards to the business and has created arguably the first co-investment funding campaign of this sort.Adrangi and Kerrisdale Capital Management have already begun to buy up shares of the company. The firm has also released content on various media platforms to show potential investors the benefits of taking part in the campaign. The unnamed company is reportedly worth upwards of $10 billion, making SahmAdrangi’s most recent alternatives fund more ambitious.Kerrisdale Capital Management has clear experience regarding investment against distressed companies through short sale positions. The company, guided by SahmAdrangi, has already acquired over $500 million in funds that it now manages, including similar short stock sales related to major pharmaceutical companies and other manufacturers.

Though Kerrisdale is small in comparison to other firms, it is having a big impact on how investing can be used.SahmAdrangi graduated from Yale University with a Bachelor’s degree in Economics and began his career in the financial sector by working with Deutsche Bank. Adrangi was specifically involved as a leveraged loan officer who managed debt loan financing and offered advisory services for bankruptcy and settlement structuring through Chanin Capital Partners. He also possesses considerable experience working at hedge funds from his time at Longacre Management.Adrangi’s influence as a prominent businessman and activist has led him to speak at numerous conferences across the globe. He has shared his knowledge and insight on television as well. SahmAdrangi was a guest on news programs for both Bloomberg and CNBC. Newspaper publications have also featured articles highlighting Adrangi and his career. These publications include the Washington Post, Wall Street Journal, and New York Times.